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Abstract Hepatitis C virus (HCV)-infected physicians
have been reported to infect some of their patients during
exposure-prone procedures (EPPs). There is no European
consensus on the policy for the prevention of this
transmission. To help define an appropriate preventive
policy, we determined the prevalence of HCV infection
among EPP-performing medical personnel in the Academic
Medical Center in Amsterdam, the Netherlands. The
prevalence of HCV infection was studied among 729
EPP-performing health care workers. Serum samples,
stored after post-hepatitis B virus (HBV) vaccination
testing in the years 2000–2009, were tested for HCV
antibodies. Repeat reactive samples were confirmed by
immunoblot assay and the detection of HCV RNA. The
average age of the 729 health care workers was 39 years
(range 18–66), suggesting a considerable cumulative
occupational exposure to the blood. Nevertheless, only
one of the 729 workers (0.14%; 95% confidence interval
[CI]: <0.01% to 0.85%) was tested and confirmed to be
positive for anti-HCVand positive for HCV RNA, which is
comparable to the prevalence of HCV among Amsterdam
citizens. Against this background, for the protection of
personnel and patients, careful follow-up after needlestick
injuries may be sufficient. If a zero-risk approach is
desirable and costs are less relevant, the recurrent screening
of EPP-performing personnel for HCV is superior to the
follow-up of reported occupational exposures.
Introduction
When an infected surgeon cuts him- or herself during an
operation, the transmission of a blood-borne virus to the
patientmay occur. Over45 reports documentthe transmission
of hepatitis B virus (HBV) from health care workers to
patients [1]. Only four cases of HIV transmission from
personnel to one or more patients are known, all before
2003, of which two cases are poorly understood [2–5].
Compared to HBV, the iatrogenic transmission of
hepatitis C virus (HCV) occurs less frequently, but several
reports document transmission from personnel to patients,
including reports on seven HCV-infected British surgeons
infecting at least 15 patients [6]. In Spain, Israel and the
USA, two anaesthesiologists and a nurse transmitted HCV
to many patients; they were addicted and injected themselves
during work [7–9].
Consensus has been reached on how to prevent the
transmission of HBV from personnel to patients [1, 6].
Most HBV transmissions occur during ‘exposure-prone
procedures’ (EPPs). EPPs are invasive procedures with the
potential for contact between the skin of the health care
worker and sharp surgical instruments, needles or sharp
tissues, in body cavities or poorly visualised/confined body
sites [1]. The prevention of HBV transmission to and from
EPP-performers is based on the vaccination of personnel,
on the screening for HBV infection of non-immune EPP-
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No European consensus has been reached for the manage-
ment of HCV- or HIV-infected personnel. Regarding HCV,
guidelines for the management of infected health care
workers vary widely. For example, in the United Kingdom,
since 2007, health care workers are excluded from EPPs if
they test positive for HCV RNA. Testing for HCV is
performed if the worker him- or herself decides that there
may have been exposure to HCV. In Ireland, since 2005,
one must undergo polymerase chain reaction (PCR) testing
if one performs EPPs. In the Netherlands, no HCV policy
has been defined. This study aims to gain insight into the
prevalence of HCV infection among Dutch medical
personnel performing EPPs in a large academic hospital in




At the Academic Medical Center (AMC) in Amsterdam, for
the monitoring of the HBV immune status of personnel,
distinction is made between persons who only run the risk
of acquiring infection and persons such as thoracocardiac,
orthopedic and gynaecological surgeons, who, in addition,
may transmit HBV to patients during EPPs. This enabled
the computer-aided selection of samples from EPP-
performing personnel. The sample collection at AMC—
Laboratory of Clinical Virology includes all submitted sera
over the last 10 years. Samples are stored at −20°C. During
2000–2009, sera from 5,190 different persons were sub-
mitted by the Occupational Health and Safety Department
for post-vaccination anti-HBs testing. Of these, 734 (14%)
were encoded as EPP-performing personnel. The exact
nature of the profession was not available. Five samples
contained no or insufficient serum. Thus, sera from 729
EPP-performing persons were available for anti-HCV
testing.
At the time of sampling, the age of the medical
personnel was, on average, 38.6 years (range 17.5–66.0);
the cumulative age was 28,147 years (Fig. 1). If it is
assumed that significant occupational exposure to blood,
and a risk of transmitting infection, occur after medical
training has been completed at an age of 25 years, this
study represents 28;147  25»729 ðÞ ¼ 9;922 person-years
of occupational exposure to and potential transmission of
blood-borne viruses. For comparison, the prevalence of
HCV infection among patients at the AMC was assessed as
follows. In the years 2005 to 2010, 1,248 needlestick
accidents and other occupational exposures were recorded
by the Occupational Health and Safety Department. In 526/
1,248 cases (42%), the HCV status of the source patient
was known or tested; 8% of the patients (44/526) were
HCV-infected.
Testing for HCV
Before testing, the 729 samples were renumbered with no
relation to the original identification. The anonymous sera
were tested for antibodies to HCV using the automated
AxSYM HCV chemiluminescent antibody assay (Abbott
Laboratories, Abbott Park, IL, USA). Initially reactive
samples, showing a sample to cut-off ratio (S/CO) ≥ 1,
were considered to be positive if they again showed
reactivity in repeated testing. Repeat reactive samples were
subjected to confirmatory testing using an immunoblot
assay for the detection of HCV antibodies (RIBA HCV 3.0
Strip Immunoblot Assay, Chiron Corporation, Emeryville,
CA, USA) and a PCR for the detection of HCV RNA
(Roche Cobas AmpliPrep/Cobas TaqMan HCV assay,
Roche Molecular Systems Inc., Pleasanton, CA, USA).
The 95% confidence interval (CI) of the HCV-positive
proportion of the tested samples was calculated using the
adjusted Wald method.
Effects of long-term storage on HCV testing
Prolonged storage may cause increased non-specific sero-
logical reactivity in the samples, while HCV RNA and
HCV antibodies may deteriorate. To assess increasing non-
specific reactivity, the anti-HCV signal distribution of the
729 archived samples was compared to the signals in 4,786
fresh samples, routinely tested for anti-HCV in 2010 on the
Fig. 1 Distribution of the age of 729 health care workers performing
exposure-prone procedures (EPPs) and tested for hepatitis C virus
(HCV) infection
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performed as follows. Serum samples from three hepatitis C
patients (patients A–C) were retrieved, which were kept in
the same freezer together with the oldest samples of this
study since 2000. Anti-HCV testing was repeated in 2011,
and the signals were compared to the original signals of
2000. On three serum samples from 2001 (patients D–F),
kept in the same freezer as the study samples, quantitative
HCV RNA was determined in 2011, and compared to the
level of HCV RNA as determined on plasma samples in
2001, using the HCV RNA bDNA assay (Siemens,
Deerfield, IL, USA).
Ethical considerations
The Medical Ethical Committee (MEC) of the AMC, the
judicial department of the AMC and the Dutch National
Health Council approved this study. The HCV testing was
performed anonymously, based on several considerations.
The samples in this study were drawn for anti-HBs testing.
Obtaining retrospective permission for non-anonymous
HCV testing was not feasible. In addition, it had to be
avoided that HCV-positive persons could have been
excluded from work, in an unregulated situation, for
example, without insurance for the loss of income, while
at the same time in other hospitals, HCV-infected personnel
remains undetected. On the other hand, knowing one’s
HCV infection status enables the timely treatment of HCV
infection. Therefore, if significant prevalences of HCV
were to be detected in this study (to be judged by the
MEC), HCV testing is planned to be advised to all EPP-
performing personnel. In addition, independent of this
study, the confidential testing and treatment of blood-
borne infections has been available for all EPP-performing
personnel at the AMC for many years.
Results
Ten of the 729 (1.4%) serum samples were positive for anti-
HCVafter repeated testing in the anti-HCV screening assay.
One sample was strongly reactive and nine samples showed
marginal anti-HCV signals (Table 1). Confirmatory testing
demonstrated the presence of HCV RNA (37,300 IU/mL)
and a complete immunoblot pattern only in the strongly
reactive sample, hence, the prevalence of HCV infection
among the health care workers was 1/729 or 0.14% (95%
CI: <0.01% to 0.85%).
In the nine weakly reactive, PCR-negative samples, the
anti-HCV immunoblot tested negative in six samples,
invalid in one, positive in one and indeterminate in one
sample (Table 1). The invalid immunoblot pattern
concerned isolated anti-NS5 reactivity together with reac-
tivity against the fusion protein, which indicates non-
specific reactivity [10]. Possibly, the weak reactivity in the
positive and indeterminate immunoblot pattern concerned
waning antibodies after cleared or cured HCV infection in
the past. The weak anti-HCV reactivity in the nine samples
may very well be non-specific. Weak signals (S/CO<3) in a
chemiluminescent anti-HCV immunoassay are associated
with false-positive reactivity [11]. In addition, comparing
the signals in the stored and fresh samples, the archived
samples show elevated background reactivity, below and
around the cut-off value (Fig. 2). It is unlikely that the
weakly reactive samples represent an early stage of HCV
infection. In that case, peak levels of HCV-RNAwould have
been present, detectable by PCR, despite the degradation of
HCV-RNA during storage (see below).
The anti-HCV signal in the stored sera of three patients
was still strongly positive upon retesting in 2011. The S/CO
ratio in 2000 and in 2011 was, respectively, in patient A
78.67 and 63.78, in patient B 81.64 and 68.75, and in
patient C 111.77 and 91.77. The HCV RNA levels in the
three patient sera from 2001 seem to be reduced upon
retesting in 2011, with test results in 2001 and in 2011 as
follows: in patient D 462,000 and 186,000 IU/mL, in
patient E 362,000 and 112,000, and in patient F 11,700 and
110 IU/mL.
Discussion
Based on look-back studies, the transmission rate of HCV
from infected surgeons to their operated patients was 0.26%
in the United Kingdom and 0.13% in Germany [6]. In
Norway, a cardiac surgeon transmitted HCV during open
heart surgery to 3.7% (n=10) of operated patients [12].
Should surgeons be screened for HCV to protect their
patients against iatrogenic infection? To define appropriate
preventive measures, the prevalence of HCV among
medical personnel must be known. This survey was
undertaken in order to estimate the prevalence of HCV
among transmission-prone medical personnel.
The screening of anonymous samples of 729 persons
who perform EPPs at the Academic Medical Center in
Amsterdam revealed only one HCV infected health care
worker (0.14%, 95% CI: <0.01% to 0.85%). After the
sampling of Amsterdam citizens, Baaten et al. calculated a
similar overall prevalence of HCV infection in Amsterdam
of 0.62% (95% CI: 0.1–1.1%). The large majority of the
HCV-positive citizens in the sampling concerned immigrants
with risk factors such as intravenous drug abuse and blood
transfusion before 1991 [13].
The low prevalence of HCV among EPP-performing
health care workers in Amsterdam is reassuring, consider-
ing that the large majority of the personnel was over
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exposure to blood in the past. Failure to detect HCV
infection in the archived samples, due to deterioration
during prolonged storage, seems unlikely. In addition, our
results are in line with the early findings of Beltrami et al.,
who reviewed seroprevalence studies among hospital-based
personnel in the 1990s, and also found HCV seroprevalence
rates comparable to or lower than in the general population
in several Western countries [14]. More recently, Marconi et
al. found no HCV infection following 390 Italian health
care workers from 1999 to 2009 [15].
Unrelated to this anonymous study, two physicians at the
AMC acquired HCV infection after a needlestick injury,
respectively, in 2000 [16] and in 2009. At first sight, these
incidents seem inconsistent with the low prevalence of
HCV infection as reported in this study. However, in both
incidents, the physician was aware of HCV infection in the
patient. Apparently, effective self-referral took place.
Obviously, both infections occurred after the sampling for
anti-HBs testing of the surgeons took place. This illustrates
that our study does not provide a cumulative measurement
of all HCV transmissions to EPP-performing personnel at
the AMC up till now; it provides a cross-sectional overview
of the HCV status of 729 workers, with careers covering
nearly 10,000 person-years of occupational exposure to
blood at the time of sampling. Nevertheless, it cannot be
ruled out that increased exposure to HCVoccurred after the
sampling of the personnel for this study took place, which
would cause an underestimation of the prevalence of HCV
in this report.
Among Amsterdam citizens, HCV infection can be
attributed to risk factors such as intravenous drug abuse,
blood transfusion before 1991 and unprotected sex between
HIV-infected men [13, 17]. HCV infection among local
surgeons can be attributed to occupational exposure to the
blood of HCV-infected patients or to personal non-
occupational risk behaviour. From an occupational health
care perspective, HCV infection among hospital-based
personnel can be an occupational disease for which simple
screening and rapidly improving antiviral therapy is
available [18, 19]. The recurrent screening of personnel
for HCV may reveal HCV infections caused by unreported
needlestick injuries and non-occupational sources. Howev-
er, in this study, only one of 729 health care workers was
found to be HCV-infected. Against this background, for the
protection of personnel and patients, the follow-up of
physicians after occupational exposures may be sufficient,
without recurrent screening of personnel for HCV infection.
Fig. 2 Distribution of the anti-HCV signal in 729 archived samples of
health care workers and in 4,786 fresh samples routinely tested for
anti-HCV (S/CO = sample to cut-off ratio; positive if ≥1)
Table 1 Confirmatory test results in ten anti-hepatitis C virus (HCV) reactive health care workers
Sample no. Anti-HCV EIA Anti-HCV immunoblot Immunoblot pattern
(c100, c33, c22, NS5, SOD)
HCV-RNA PCR
Initial S/CO Repeat S/CO
1 59.80 51.32 Positive 4+, 4+, 4+, 4+, 0 Positive, 37,300 IU/mL
2 2.21 2.29 Invalid 0, 0, 0, 4+, 2+ Negative
3 2.65 2.28 Positive 0, 1+, 2+, 0, 0 Negative
4 1.39 1.47 Negative 0, 0, 0, 0, 0 Negative
5 1.11 1.12 Indeterminate 0, 1+, 0, 0, 0 Negative
6 1.24 1.09 Negative 0, 0, 0, 0, 0 Negative
7 2.95 1.04 Negative 0, 0, 0, 0, 0 Negative
8 1.21 1.02 Negative 0, 0, 0, 0, 0 Negative
9 1.18 1.02 Negative 0, 0, 0, 0, 0 Negative
10 1.37 1.01 Negative 0, 0, 0, 0, 0 Negative
C100, c33, c22 and NS5=artificial HCV antigens
SOD = superoxide dismutase, fusion protein
S/CO = sample to cut-off ratio; positive if ≥1
1476 Eur J Clin Microbiol Infect Dis (2012) 31:1473–1477Recurrent screening is less productive if the incidence of
HCV is low and a careful follow-up of occupational
exposures takes place, but it is superior to the follow-up
of reported needlestick injuries if a zero-risk approach is
desirable and costs are less relevant.
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